RAD — Radiopharm Theranostics Share News
0.000.00%
Last trade - 00:00- AU$15.95m
- AU$9.45m
- AU$2.77m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:25 AM
NASDAQ RESUMED AT 10:17 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:10 AM
NASDAQ RESUMED AT 09:58 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:53 AM
NASDAQ RESUMED AT 09:51 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:46 AM
NASDAQ RESUMED AT 09:45 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:40 AM
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
Brief: Radiopharm Theranostics Achieves Primary Endpoint In 92% Of Patients At Interim Analysis Of Rad 101 Phase 2B Imaging Trial In Brain Metastases
NASDAQ RESUMED AT 02:11 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:06 PM
Brief: Radiopharm Theranostics Announces 50% Enrollment In Phase 2B Clinical Trial Of Rad101 Imaging In Brain Metastases
Australia's Radiopharm Theranostics slumps on discounted placement
Brief: Radiopharm Theranostics Completes A$35 M Placement
Brief: Radiopharm Theranostics Ltd Seeks Trading Halt
Brief: Radiopharm Gets DSMC Nod To Accelerate Phase 1 Dose Escalation Trial Of 177Lu-RAD202